Menu Search
Equities

Kenvue Inc

KVUE:NYQ

Kenvue Inc

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)22.90
  • Today's Change-0.29 / -1.25%
  • Shares traded13.62m
  • 1 Year change+8.74%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy1
Outperform6
Hold8
Sell0
Strong Sell1

Share price forecast in USD

The 12 analysts offering 12 month price targets for Kenvue Inc have a median target of 22.00, with a high estimate of 25.00 and a low estimate of 18.00. The median estimate represents a -3.93% decrease from the last price of 22.90.
High9.2%25.00
Med-3.9%22.00
Low-21.4%18.00

Dividends in USD

In 2023, Kenvue Inc reported a dividend of 0.40 USD. The 10 analysts covering the company expect dividends of 0.80 USD for the upcoming fiscal year, an increase of 98.75%.
Div growth (TTM)--
More ▼

Earnings history & estimates in USD

On Aug 06, 2024, Kenvue Inc reported 2nd quarter 2024 earnings of 0.32 per share. This result exceeded the 0.28 consensus of the 10 analysts covering the company and was the same as last year's 2nd quarter results.
The next earnings announcement is expected on Oct 24, 2024.
Average growth rate+0.37%
Kenvue Inc reported annual 2023 earnings of 1.29 per share on Feb 08, 2024.
More ▼

Revenue history & estimates in USD

Kenvue Inc had 2nd quarter 2024 revenues of 4.00bn. This bettered the 3.94bn consensus of the 11 analysts covering the company. This was 3.84% above the prior year's 2nd quarter results.
Average growth rate+0.05%
Kenvue Inc had revenues for the full year 2023 of 15.44bn. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.